Alta Partners — 2014 Investments

2 investments dated 2014 · listed companies and verified rows first · show all

Esperion Therapeuticsesperion.comJun 2014

BiotechAnn Arbor, US

Antonio M. Gotto, Jr.(Director)Tim M. Mayleben(Executive Officer, Director)Gilbert S. Omenn(Director)Daniel Janney(Director)Dov A. Goldstein(Director)Roger S. Newton(Director)

PartnerDan Janney· led

Co-investorsAisling Capital Arboretum Ventures ARCHIMED Japan Asset Management Company Canaan Partners Longitude Capital+2 more

Kite Pharmakitepharma.com inApr 2014

Kite Pharma develops CAR T-cell therapies for cancer patients, engineering the immune system's cells to target and attack cancer.

BiotechHealthtechSanta Monica, US

Arie S. Belldegrun(Executive Officer, Director)Margo R. Roberts(Executive Officer)Cynthia Butitta(Executive Officer)Marc Better(Executive Officer)Rizwana Sproule(Executive Officer)

BoardJoshua A. Kazam(Director)

Co-investorsPontifax Venture Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.